Deere & Company’s Impax Laboratories, Inc. IPXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-21,895
Closed -$519K 936
2016
Q3
$519K Sell
21,895
-35,972
-62% -$967K 0.03% 592
2016
Q2
$1.67M Buy
+57,867
New +$1.89M 0.09% 207
2015
Q2
Sell
-48,133
Closed -$2.26M 1164
2015
Q1
$2.26M Sell
48,133
-29,938
-38% -$1.19M 0.12% 177
2014
Q4
$2.47M Buy
+78,071
New +$2.28M 0.13% 161
2014
Q1
Sell
-25,701
Closed -$646K 1110
2013
Q4
$646K Hold
25,701
0.03% 598
2013
Q3
$526K Sell
25,701
-2,901
-10% -$59.9K 0.03% 632
2013
Q2
$570K Buy
+28,602
New +$508K 0.03% 567

Other funds holding IPXL

Deere & Company's IPXL Position: Q4 2016 in Review

Deere & Company sold out of Impax Laboratories, Inc. (IPXL) in Q4 2016, closing a stake of 21,895 shares — an estimated $519K sold.

Deere & Company first reported a position in IPXL in Q2 2013 and held it in 7 quarters. The position peaked at $2.47M in Q4 2014. 198 funds tracked by Wall St. Rank hold IPXL as of Q4 2016.

  • Deere & Company reported no remaining Impax Laboratories, Inc. position as of Q4 2016 after selling out during the quarter.
  • Deere & Company sold 21,895 Impax Laboratories, Inc. shares in Q4 2016, an estimated $519K.
  • Deere & Company first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 7 quarters.
  • Deere & Company's Impax Laboratories, Inc. position peaked at $2.47M in Q4 2014.
  • 198 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2016.

Based on Deere & Company's 13F filing for Q4 2016, filed 13 Feb 2017.